SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

Share Price is delayed by 15 minutes
Get Live Data
129.00    0.00 (0.00%)
Bid:
127.00
Ask:
131.00
Spread: 4.00 (3.15%)
Market Cap: £1.18b
NBS Live PriceLast checked at - London Stock Exchange

Intraday Nationwide Ccds Share Chart

Supplement and Interim Results

18 Nov 2016 12:41

RNS Number : 5975P
Nationwide Building Society
18 November 2016
Β 

Publication of Supplement

Β 

The following supplement to a prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Β 

Nationwide Building Society

Supplement dated 18 November 2016 to the Base Prospectus dated 31 August 2016, prepared in connection with the U.S.$25,000,000,000 European Note Programme, to the Base Prospectus dated 29 July 2016, prepared in connection with the €45,000,000,000 Global Covered Bond Programme, and to the Base Prospectus dated 23 June 2016, prepared in connection with the U.S.$20,000,000,000 Senior and Subordinated Medium-Term Note Programme, each established by Nationwide Building Society.

Β 

To view the full document, please paste the following URL into the address bar of your browser:

Β 

http://www.rns-pdf.londonstockexchange.com/rns/5975P_-2016-11-18.pdf

Β 

Interim Results

Β 

http://www.rns-pdf.londonstockexchange.com/rns/5975P_1-2016-11-18.pdf

Β 

A copy of the Supplement and the Interim Results will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do.

Β 

For further information, please contact

Β 

Nationwide Building Society

One Threadneedle Street

London EC2R 8AW

Β 

Telephone: 0845 602 9053

Attention: Sarah Gardiner/Nicole Woodrow

Β 

DISCLAIMER - INTENDED ADDRESSEES

Β 

Please note that the information contained in the Base Prospectuses (as supplemented by the Supplement) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectuses) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectuses is not addressed. Prior to relying on the information contained in the Base Prospectuses you must ascertain from the Base Prospectuses whether or not you are part of the intended addressees of the information contained therein.

Β 

Your right to access this service is conditional upon complying with the above requirement.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
PSPLVLFFQFFLFBK
Date   Source Headline
12th Jun 20262:02 pmRNSPublication of a Prospectus
12th Jun 202611:31 amRNSPublication of Registration Document
12th Jun 202611:24 amRNSPublication of a Prospectus
9th Jun 202611:15 amRNSAdmission to Trading
8th Jun 202611:52 amRNSNOTICE TO NOTEHOLDERS
5th Jun 20262:58 pmRNSPublication of Final Terms
21st May 202612:33 pmRNSPublication of a Supplementary Prospectus
21st May 20267:00 amRNSPreliminary Results Announcement
6th May 20263:12 pmRNSPublication of Final Terms
21st Apr 20263:38 pmRNSPublication of Final Terms
21st Apr 202610:20 amRNSCancellation of Listing
20th Apr 202612:38 pmRNSNotice to Covered Bondholders
9th Apr 202611:06 amRNSPublication of a Supplementary Prospectus
7th Apr 20267:00 amRNSPart VII Transfer & Board changes
20th Mar 20268:48 amRNSRedemption of Securities
3rd Mar 202611:50 amRNSAdmission to Trading
3rd Mar 202611:44 amRNSAdmission to Trading
27th Feb 20265:18 pmRNSPublication of Final Terms
27th Feb 20263:56 pmRNSPublication of Final Terms
26th Feb 202611:00 amRNSPart VII Transfer
24th Feb 20269:51 amRNSAdmission to Trading
20th Feb 20269:47 amRNSPublication of Final Terms
19th Feb 202610:04 amRNSAdmission to Trading
17th Feb 20269:56 amRNSAdmission to Trading
17th Feb 20269:46 amRNSPublication of Final Terms
13th Feb 20262:04 pmRNSPublication of Final Terms
13th Feb 20268:15 amRNSPost Stabilisation Notice
3rd Feb 20262:41 pmRNSAdmission to Trading
30th Jan 20261:00 pmRNSPublication of Final Terms
16th Jan 20261:21 pmRNSPublication of Final Terms
8th Jan 20261:49 pmRNSPublication of Final Terms
8th Jan 20267:00 amRNSDirectorate change
7th Jan 202610:49 amRNSPre Stabilisation Notice
19th Dec 202511:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirectorate change
16th Dec 20252:42 pmRNSPublication of a Supplementary Prospectus
2nd Dec 20257:10 amRNSResponse to 2025 BOE Capital Stress Test Results
2nd Dec 20257:00 amRNSRevocation of Sub-consolidation Direction
20th Nov 202511:47 amRNSPublication of Supplement
20th Nov 20257:00 amRNSInterim Results September 2025
14th Nov 202511:00 amRNSPart VII Transfer
21st Oct 20251:08 pmRNSPublication of Final Terms
10th Oct 202512:52 pmRNSPublication of Final Terms
1st Oct 20257:00 amRNSConfirmation of Post-Offer Intention Statements
30th Sep 202510:03 amRNSBoard Changes
30th Sep 20259:43 amRNSBoard Changes
30th Sep 20257:00 amRNSBoard Changes
26th Sep 20252:49 pmRNSPublication of Final Terms
16th Sep 20251:48 pmRNSPublication of Final Terms
8th Sep 202511:27 amRNSPublication of Final Terms

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.